.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,558,679

« Back to Dashboard

Details for Patent: 6,558,679

Title: Container for an inhalation anesthetic
Abstract:A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
Inventor(s): Flament-Garcia; Mary Jane (Gurnee, IL), Cromack; Keith R. (Lake Bluff, IL), Loffredo; David (Elmhurst, IL), Raghavan; Rajagopalan (Grayslake, IL), Ramsay; George M. (Waukegan, IL), Speicher; Earl R. (Buffalo Grove, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Filing Date:Dec 19, 2000
Application Number:09/740,463
Claims:1. A pharmaceutical product comprising: a container constructed from a material comprising a polyester having an integral double ring structure, said container defining an interior space; and a volume of sevoflurane contained in said interior space defined by said container.

2. A pharmaceutical product in accordance with claim 1, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said pharmaceutical product further comprising a cap, said cap constructed to seal said opening defined in said container, said cap comprising a material comprising a compound selected from a group consisting of polyesters having integral double ring structures, polymethylpentene, and combinations thereof.

3. A pharmaceutical product in accordance with claim 1, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said pharmaceutical product further comprising a cap having an interior surface, said cap constructed to seal said opening defined in said container, said interior surface of said cap constructed from a material comprising a compound selected from a group consisting of polyesters having integral double ring structures, polymethylpentene, and combinations thereof.

4. A pharmaceutical product comprising: a container defining an interior space, said container having an interior surface adjacent to said interior space, said interior surface constructed from a material comprising a polyester having an integral double ring structure; and a volume of sevoflurane contained in said container.

5. A pharmaceutical product in accordance with claim 4, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said pharmaceutical product further comprising a cap, said cap constructed to seal said opening defined in said container, said cap constructed from a material comprising a compound selected from a group consisting of polyesters having integral double ring structures, polymethylpentene, and combinations thereof.

6. A pharmaceutical product in accordance with claim 4, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said pharmaceutical product further comprising a cap having an interior surface, said cap constructed to seal said opening defined in said container, said interior surface of said cap constructed from a material comprising a compound selected from a group consisting of polyesters having integral double ring structures, polymethylpentene, and combinations thereof.

7. A method for storing an inhalation anesthetic, said method comprising the steps of: providing a predetermined volume of sevoflurane; providing a container defining an interior space, said container constructed from a material comprising a polyester having an integral double ring structure; and placing said predetermined volume of sevoflurane in said interior space defined by said container.

8. A method for storing an inhalation anesthetic, said method comprising the steps of: providing a predetermined volume of sevoflurane; providing a container defining an interior space, said container having an interior wall adjacent said interior space defined by said container, said interior wall of said container constructed from a material comprising a polyester having an integral double ring structure; and placing said predetermined volume of sevoflurane in said interior space defined by said container.

9. A method for storing an anesthetic agent in accordance with claim 8 wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said method further comprising the steps of: providing a cap constructed to seal said opening defined by said container, said cap having an interior surface constructed from a material comprising a compound selected from a group consisting of polyesters having integral double ring structures, polymethylpentene and combinations thereof; and sealing said opening defined in said container with said cap.

10. A pharmaceutical product in accordance with claim 1, wherein said polyester having an integral double ring structure is a polyethylene naphthalate homopolymer.

11. A pharmaceutical product in accordance with claim 4, wherein said polyester having an integral double ring structure is a polyethylene naphthalate homopolymer.

12. A method for storing an inhalation anesthetic in accordance with claim 7, wherein said polyester having an integral double ring structure is a polyethylene naphthalate homopolymer.

13. A method for storing an inhalation anesthetic in accordance with claim 8, wherein said polyester having an integral double ring structure is a polyethylene naphthalate homopolymer.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc